The minimally invasive technique leads to shorter hospital stays, reduced bleeding, and allows flexibility for future procedures, if needed.
Multi-Focus Seizures Complicate Surgical Treatment for Pediatric Epilepsy Case
A functional hemispherectomy at CHOC gave Jaylynn the best outcome for seizure control and turned around her quality of life.
Silk Biomaterial Research Advances Urologic Treatment Capabilities
The Urology Center at CHOC is collaborating with Joshua Mauney, PhD and Jerry D. Choate Presidential Chair in Urology Tissue Engineering in UC Irvine.
Clinical trials continue the advancement of pediatric oncology treatment
CHOC currently offers more than 140 clinical trials in varying phases, including multiple pharmaceutical industry-sponsored clinical trials.
Investigational Drug Study Leads to FDA Approval for Fenfluramine in Treatment for Dravet Syndrome
Dr. Mary Zupanc was a key investigator in a study that led to FDA approval for a medication to treat children with Dravet syndrome.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
